Compare Charles River Laboratories Intl. Inc (CRL) vs iShares Silver Trust (SLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs iShares Silver Trust — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while iShares Silver Trust trades at $54.78 (market cap $29.02B). The key difference: iShares Silver Trust is far larger — about 2× Charles River Laboratories Intl. Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, iShares Silver Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and iShares Silver Trust for 89 Days on average.
| CRL | SLV | |
|---|---|---|
Market Cap | $14.23B | $29.02B |
Volume | 1,176,885 | 16,510,334 |
Sector | Health | — |
52-Week High | $310.77 | $105.57 |
52-Week Low | $149.93 | $42.40 |
Typical Hold Time | 33 Days | 89 Days |
Enterprise Value | $17.06B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298, down 0.77% on the day, with strong analyst support showing 73% buy ratings and a $305.50 consensus price target. The stock maintains a bullish technical outlook with support at $292 and resistance at $301, while recent earnings have consistently beaten expectations despite negative net income margins. The company's 2026 Investor Day highlighted a strategic vision targeting 5-7% organic growth and $300 million in savings by 2030.
CRL presents a compelling growth story with solid operational cash flow and strategic initiatives, though investors face risks from negative profitability metrics and elevated valuation multiples. The stock's current position near analyst targets suggests limited upside without improved earnings execution, while ongoing margin pressures and debt levels require careful monitoring amid the company's transformation efforts.
SLV (iShares Silver Trust) trades at $53.45, down 0.69% with a bearish technical signal. The ETF shows minimal operational activity with $0 revenue but generated $2.17M net income in 2024. Assets surged to $13.41B while liabilities remain negligible at $5.98K. Technical indicators show oversold conditions with RSI at 26.02, though moving averages signal continued bearish pressure.
The outlook remains challenged by Federal Reserve policy uncertainty and rising Treasury yields pressuring precious metals. While oversold conditions may provide short-term bounce potential, the fundamental case lacks revenue generation. Investors face headwinds from dollar strength and hawkish Fed expectations, requiring careful risk management in this volatile sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About iShares Silver Trust
The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →
